AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer
Updated
Written By
Sarah Avery
Director, Duke Health News Office
Related News
Clinical Practice Today
Duke Pathology
Related News
Clinical Practice Today
Duke Pathology
This page was reviewed
on 06/01/2023